EN | FR
Company :: Publications
Publications
ABL
collaborates with our clinical advisors and partners on publications
for journals and conferences.
If you have a similar interest and would like to co-publish with us, please send an email to partners@ablsa.com.
Publication Compilation
ABL Insight is a newsletter that contains all of our publications and research projects for the year.
ABL Insight :: 2004 Download the PDF :: 1.2Mb
(To download, right-click on the link and select "save target as")
Abstracts and Posters
Storing genotypic resistance data and linking to other clinical information.
R. Boulme, D. Gonzalez and JC. Schmit. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004.
Patterns of resistance mutations in B versus non-B patients with previous PI failure.
S. De Wit, R. Boulme, B. Poll, D. Konopnick, JC. Schmit, N. Clumeck. 2nd European HIV Drug Resistance Workshop, 11- 13 March, 2004, Roma , Italy.
Predictive Factors Associated with Virologic Success in Highly Pre-Treated HIV-Infected Patients Receiving Boosted Amprenavir : A PharmAdapat Substudy.
Clevenbergh P., Boulme R., Kirstetter M., Dellamonica P. 9TH EUROPEAN AIDS CONFERENCE (EACS) - 1st EACS RESISTANCE & PHARMACOLOGY WORKSHOP - October 25 - 29, 2003 Warsaw • Poland - Poster 7.4/7
VIRAL LOAD AND CD4 RESPONSE TO PI CONTAINING REGIMEN IN B VERSUS NON-B TREATMENT-NAIVE HIV-1 PATIENTS.
S. De Wit, R. Boulme, B. Poll, JC. Schmit, N. Clumeck. 2nd IAS Conference on Pathogenesis and Treatment, Paris, July 13-16 2003.
Does HIV-1 subtype influence the results of drug resistance interpretation algorithms ?
JJC. Schmit, D. Gonzalez, R. Boulme. XII International HIV Drug Resistance Workshop, June 10 - 14, 2003 Los Cabos, Mexico.
Comparison of different tenofovir DF resistance algorithms
R Boulme, D Gonzalez, and JC Schmit. 1st European HIV Drug Resistance Workshop, March 6 - 8, 2003 Luxembourg - Poster 3.5.
Efficacy of boosted amprenavir in the salvage therapy of highly antiretroviral experienced HIV-1 infected patients.
Clevenbergh P., Boulme R., Kirstetter M., Dellamonica P. 1st European HIV Drug Resistance Workshop, March 6 - 8, 2003 Luxembourg.
Nelfinavir-containing regimen in treatment-naive HIV-1 patients : comparison of efficacy in B versus non-B subtypes
S De Wit, R Boulme, B Poll, N Clumeck, JC Schmit, O Van Der Meeren. VI International Congress on Drug Therapy in HIV Infection, 17-21 November 2002, Glasgow , UK - P195.
Nelfinavir (NFV): 12-Month Safety and Efficacy vs. Boosted-Indinavir (IDV/RTV), each in combination with 2 NRTIs, in Treatment Naive Patients
S. De Wit, R Boulme, D. Konopnicki, B. Sommereijnns, J. Protto, N. Clumeck. 42nd ICAAC, American Society for Microbiology, September 27 - 30, 2002, San Diego, CA, page 262 - Abstract: H-168.
No Evidence of Primary Resistance to T-20 in Treatment-Naive Patients Infected with Non-B HIV-1 Isolates
F Roman, D Gonzalez, R Boulme, A Fischer, T Baurith, V Arendt, F Schneider, R Hemmer and JC Schmit. XIV International AIDS Conference, World Congress, Barcelona, Spain - Paper # 3026.
A Centralized Database System for The Management and Processing of HIV-Related Information
R. Boulme, D. Gonzalez, I. Robert, A. Ternes and J.C. Schmit. XIV International AIDS Conference, World Congress, Barcelona, Spain - Paper # 4840.
Nelfinavir versus Indinavir/Ritonavir in Treatment Naive Patients : Comparison of Efficacy and Safety at One Year.
S. De Wit, R. Boulme, D. Konopnicki, B. Sommereijns, JP. Protto, O. Van Der Meeren and N. Clumeck. XIV International AIDS Conference, World Congress, Barcelona, Spain - Paper # 4446.
Resistance Testing in HIV-1 Infected Patients Treated with Indinavir/Ritonavir 800mg/100mg BID After at Least One Protease Inhibitor-Based Therapy Failure.
R. Boulme, S. De Wit, C. Necsoi, B. Sommereijns, JC. Schmit and N. Clumeck. XIV International AIDS Conference, World Congress, Barcelona, Spain - Paper # 4472.
Determination of the Optimal Cut-offs for Predicting the Phenotype of Nine Different HIV Drug Resistance Algorithms.
N Zeitler, B Schmidt, K Korn, W Keulen, CAB Boucher, N Beerenwinkel, J Selbig, A-M Vandamme, DL Winslow, R Shafer, JM Schapiro, R Boulme, JC Schmit and H Walter. XI International HIV Drug Resistance Workshop, Sevilla, Spain.
New Mutations at Residue Positions Critical for T-20 Resistance in T-20 Naive Patients Infected with Clade B HIV-1 Isolates.
F Roman, D Gonzalez, R Boulme, C Lambert, S Deroo, A Fischer, T Baurith, T Staub, V Arendt, F Schneider, R Hemmer and JC Schmit. XI International HIV Drug Resistance Workshop, Sevilla, Spain.
Molecular Tridimensional Phenotyping Predicts HIV-1 Protease Inhibitor Resistance.
G Pepe, J Courcambeck, J Durant, P Dellamonica, R Boulme and P Halfon. XI International HIV Drug Resistance Workshop, Sevilla, Spain.
Comparison of HIV-1 Protease Inhibitor Susceptibility Results in Viremic Protease Inhibitor(PI)-Experienced Patient Samples Analyzed by Phenotyping and by Five Resistance Algorithms.
D. Paulsen, A. Florance, Q. Liao, R. Boulme, M. Shaefer, G. Fusco, L. Ross. XI HIV Drug Resistance Workshop, Sevilla, Spain.
Virological Response to Salvage Therapy at 6 Months in Patients with B or Non-B Subtypes.
Hermans P, Schmit JC, Kabeya K, Boulme R, Protto JP, ODoherty E, De Wit S, Sommereinjs B and Clumeck N. 9th Conference on Retroviruses and Opportunistic Infections (CROI), Seattle, Washington, USA - Paper # 427-W.
Analysis of Mutational Patterns Associated with Resistance to Tenofovir DF and Lopinavir/ritonavir.
R. Boulme, O. Dugas, P. Halfon, R. Diaz and JC. Schmit. 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece - Paper #352.
HIV-1 Subtype Determination in Routine Clinical Samples from 5 Countries Using an Internet-Based Subtyping Tool.
R. Boulme, O. Dugas, I. Robert, R. Hemmer, V. Arendt, T. Staub, B. Schmidt, H. Walter, K. Korn, P. Halfon, N. Clumeck, P. Hermans, S. Dewit, R. Diaz and JC. Schmit. 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece - Paper #366.
HIV-1 Subtype Characterization Using Automated Internet-Based Resources.
R Boulme, O Dugas, JM Zimmer, D Gonzalez and JC Schmit. 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC ), Chicago, Illinois - Paper #1967.
Comparative evaluation between five automated resistance interpretation algorithms.
R. Boulme, P. Halfon, R. Diaz, O. Dugas, and JC Schmit. 5th international workshop on drug resistance and treatment strategies, Scottdale, AZ, USA. 4-8 June 2001.